NCT00392002View on ClinicalTrials.gov

Examine National Characteristics & Outcome Measures of GERD Patients Using the PPI Acid Suppression Symptom (PASS) Test for Response

PHASE4CompletedINTERVENTIONAL

Enrollment

2,000

Participants

Timeline

Start Date

October 31, 2005

Study Completion Date

May 31, 2007

Conditions

Gastroesophageal Reflux

Interventions

DRUG

Esomeprazole

Trial Locations (2)

Unknown

Research Site, Mississauga

Research Site, Toronto

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY